Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Collaboration and cooperation in hematology-oncology research

Emery Bresnick • 12 Oct 2017
ESH 2017
General

To efficiently produce effective therapies, it is necessary for experts within different specialties to collaborate. At the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Haematology (ESH), Emery Bresnick, PhD, from the University of Wisconsin, Wisconsin, WI, discusses the benefits of utilizing a collaborative research method in hematology-oncology, referencing insightful examples to exemplify this approach.

More from Emery Bresnick

3:00
GATA2 and its influence on AML
Emery Bresnick • 12 Oct 2017

Related Videos

0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:44
PHOEBUS trial: oral fecal microbiotherapy for increasing OS in patients undergoing alloSCT
Florent Malard • 11 Apr 2024
2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
3:29
PTCy as GvHD prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals